Dr. Busam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1997
- Albert Ludwigs University Faculty of MedicineClass of 1988
Certifications & Licensure
- MI State Medical License 2003 - 2026
- NH State Medical License 2022 - 2026
- CA State Medical License 2019 - 2025
- NJ State Medical License 2021 - 2025
- NY State Medical License 1996 - 2025
- MA State Medical License 1995 - 2024
- IL State Medical License 2022 - 2023
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 1036 citationsMutations in GNA11 in Uveal MelanomaCatherine D. Van Raamsdonk, Klaus G. Griewank, Michelle B. Crosby, Maria C. Garrido, Swapna S. Vemula
The New England Journal of Medicine. 2010-12-01 - 23 citationsCK7 expression in primary cutaneous squamous cell carcinomaMelissa Pulitzer, Garrett Desman, Klaus J. Busam
Journal of Cutaneous Pathology. 2010-09-01 - 233 citationsGuidelines of care for the management of basal cell carcinoma.Christian L. Baum, Jeremy S. Bordeaux, Marc Brown, Klaus Busam, Daniel B. Eisen
Journal of the American Academy of Dermatology. 2018-03-01
Journal Articles
- Massively Parallel Sequencing Analysis of Benign Melanocytic NeviAllan C Halpern, Travis J Hollmann, Klaus J Busam, Histopathology
- Reflectance Confocal Microscopic and en Face Histopathologic Correlation of the Dermoscopic “Circle Within a Circle” in Lentigo MalignaKlaus J Busam, Ashfaq A Marghoob, JAMA
- Comparison of Melanoma Gene Expression Score with Histopathology, Fluorescence in Situ Hybridization, and SNP Array for the Classification of Melanocytic NeoplasmsKlaus J Busam, Kelly Morrissey Williams, Nature
Press Mentions
- DermTech Announces Three New Scientific Advisory Board MembersJune 2nd, 2021
- Specialty-Trained Pathologists More Likely to Make Higher-Grade Diagnoses for Melanocytic LesionsNovember 18th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: